The global Liquid Biopsy Market is projected to expand from USD 3.8 billion in 2023 to USD 9.4 billion by 2032, growing at a robust CAGR of 10.7% during the forecast period (2024–2032). This rapid growth is fueled by increasing demand for non-invasive diagnostic methods, rising cancer incidence globally, and expanding applications of precision oncology.
Liquid biopsy is transforming...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek